Vital Biopharmaceutical Insights and Analytics

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Featured Report
Acute Ischemic Stroke

Sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan....Learn More

Featured Webinar
Despite Physicians' Conservative Attitude Towards Biosimilars, TNF-Alpha Inhibitors Stand to Lose $22 Billion in Sales

December 3, 2009...Learn More

View Webinar schedule and archive

Search Reports

Filter results:

TOP TEN REPORTS

See which reports have been searched on the most.

In the Spotlight

Save on Treatment Algorithms Insight Series reports
Until December 18, Decision Resources is offering a special promotion on its Treatment Algorithms Insight Series reports. The more reports you buy the more you’ll save so act now and don’t miss out on this limited time opportunity...Learn More

Latest Press Releases [ view all ]

November 19, 2009

Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia in Europe...Read More
November 18, 2009

Sales of Therapies to Treat Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy Will Increase by More than 70 Percent Through 2018...Read More
November 17, 2009

Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing from $360 Million in 2008 to $450 Million in 2018...Read More

Recent Reports [ view all ]

Bipolar Disorder

Bipolar disorder (BPD) is a chronic and debilitating psychiatric illness across all major pharmaceutical markets. Drug... Read More
Regulatory and Legislative Activities: Shaping Biomarker and Diagnostic Use and Driving Personalized Medicine

Successful navigation of the regulatory maze is a prerequisite for companies using biomarkers and diagnostics to... Read More
Gastric Cancer

Gastric cancer (GC) is the fourth-most common malignancy in terms of incidence and is the second-most common cause of... Read More